Cbt for Psychosis and Affect on Psychosis Symptoms (cbtpaps)
Primary Purpose
Psychosis
Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
cognitive behaviour therapy
Espidone
Olepra
Donu
Sponsored by
About this trial
This is an interventional treatment trial for Psychosis focused on measuring cognitive behaviour therapy, first episode
Eligibility Criteria
Inclusion Criteria:
- Patients diagnosed with psychosis by psychiatrist of the recruiting unit.
- Patients with duration of illness till 3 years.
- Patients with the minimum of 5 years of education.
- Patients within the age range of 18 to 35 years.
- Competent and willing to give informed consent.
- Patients living in the study catchment area.
Exclusion Criteria:
- Patients with drug induced psychosis.
- Patients with severe psychopathology, unable to give informed consent.
- Patients suffering from organic or neurological disorder.
- Patients suffering from chronic physical condition.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Espidone, Olepra, Donu & C.B.T
Espidone, Olepra & Donu
Arm Description
Espidone tablet 2 mg and Donu 10 mg by mouth twice a day and Olepra tablet 5 mg by mouth at night and C.B.T 6 session program 45 minutes session after every 15 days
Espidone tablet 2 mg and Donu 10 mg by mouth twice a day Olepra tablet 5 mg by mouth at night
Outcomes
Primary Outcome Measures
50 participant with schizophrenia assessed by PANSS
30 item question ask from participant
50 participant with schizophrenia assessed by SAI
three question each have two parts
50 participant with schizophrenia assessed by PSRS
6 item on delusion and 11 item on auditory hallucination
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02653729
Brief Title
Cbt for Psychosis and Affect on Psychosis Symptoms
Acronym
cbtpaps
Official Title
Cognitive Behaviour Therapy for Psychosis in First Episode Patient and the Outcome of Cognitive Behaviour Therapy on Psychotic Symptoms
Study Type
Interventional
2. Study Status
Record Verification Date
January 2016
Overall Recruitment Status
Completed
Study Start Date
September 2015 (undefined)
Primary Completion Date
January 2016 (Actual)
Study Completion Date
January 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Aisha Andleeb
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study aims to examine the effectiveness of cognitive behavior therapy for psychosis in first episode patients and see the outcome of CBT on psychotic symptoms. Because cognitive behavior therapy mostly use in depressive patient to treat the negative thinking pattern Cognitive behavioral approaches in the treatment of psychosis have become more prevalent in recent years for a number of reasons. Evidence has been available for the past two or three decades regarding the success of these techniques with other forms of psychopathology such as depression, anxiety disorders, and medical problems. Anxiety, depression and low self-esteem have been cited as the most common consequences of psychotic disorders. The observation has also emerged that many patients develop their own coping strategies for reducing the frequency, severity, and disruptiveness of their symptoms. There has also been increasing evidence regarding the influence of social environmental factors on the course of psychosis and the development of stress-vulnerability models to explain these relationships. Research suggests that 20 to 50 percent of persons with psychosis who receive neuroleptics continue to experience difficulties related to their psychotic symptoms.
Detailed Description
This research aims to examine the effect of cognitive and behavior therapy for psychosis in first episode patients and see the outcome of CBT on psychotic symptoms.
Cognitive and Behavior Therapy for Psychosis
Cognitive behavioral therapy (CBT) is talking therapy that can help to manage problems by changing the way you think and behave.
There are notable clinical successes in treating common emotional disorders using cognitive-behavioral approaches based on precise theoretical models. In anxiety disorders, the underlying fear beliefs are tested in behavioral experiments to substantially reduce symptoms; in depression, mood is lifted by reevaluating negative views of the self and limiting excessive rumination.
With psychosis, similar psychological processes are active in the experience of delusions and hallucinations. For example, persecutory delusions are conceptualized as threat beliefs that are the patient's attempts to make sense of his or her personal experiences, while hallucinations are problematic when they are interpreted by the patient as representing powerful and destructive forces. Hence, in cognitive therapy for psychosis, fearful thoughts are carefully reevaluated; withdrawal from social contact and activity is gradually reversed; and feelings of hope, control, and self-worth are fostered. Patients with psychosis are given time to talk about their experiences and, importantly, strategies are developed from this collaborative discussion.
In this one-on-one therapy, distressing experiences take center stage. The first generation of cognitive-behavioral therapy (CBT) for psychosis, when added to standard care, has demonstrated efficacy in treating patients with delusions and hallucinations.
Psychosis Psychosis is a serious mental disorder characterized by thinking and emotions that are so impaired, that they indicate that the person experiencing them has lost contact with reality.
People with psychosis are described as psychotic. People experiencing psychosis may exhibit some personality changes and thought disorder. Depending on its severity, this may be accompanied by unusual or bizarre behavior, as well as difficulty with social interaction and impairment in carrying out daily life activities.
The term "psychosis" is very broad and can mean anything from relatively normal aberrant experiences through to the complex and catatonic expressions of schizophrenia and bipolar type 1 disorder. In properly diagnosed psychiatric disorders (where other causes have been excluded by extensive medical and biological laboratory tests), psychosis is a descriptive term for the hallucinations, delusions, sometimes violence, and impaired insight that may occur. Psychosis is generally the term given to noticeable deficits in normal behavior (negative signs) and more commonly to diverse types of hallucinations or delusional beliefs, especially as regards the relation between self and others as in grandiosity and paranoia.
Objectives
To explore the effect of cognitive behavior therapy for psychosis in first episode patients.
To develop a guide to conduct cognitive behavior therapy in early psychosis patients.
To evaluate the major clinical outcomes in the treatment of psychotic symptoms.
To examine the feasibility of cognitive behavior therapy in psychotic patients. Rationale of the study This study aims to examine the effectiveness of cognitive behavior therapy for psychosis in first episode patients and see the outcome of CBT on psychotic symptoms. Because cognitive behavior therapy mostly use in depressive patient to treat the negative thinking pattern
Cognitive behavioral approaches in the treatment of psychosis have become more prevalent in recent years for a number of reasons. Evidence has been available for the past two or three decades regarding the success of these techniques with other forms of psychopathology such as depression, anxiety disorders, and medical problems. Anxiety, depression and low self-esteem have been cited as the most common consequences of psychotic disorders. The observation has also emerged that many patients develop their own coping strategies for reducing the frequency, severity, and disruptiveness of their symptoms. There has also been increasing evidence regarding the influence of social environmental factors on the course of psychosis and the development of stress-vulnerability models to explain these relationships. Research suggests that 20 to 50 percent of persons with psychosis who receive neuroleptics continue to experience difficulties related to their psychotic symptoms.
The therapeutic process consists of helping the patient become aware of his or her internal stream of thoughts when distressed, and to identify and modify the dysfunctional thoughts. Behavioral techniques are used to bring about functional changes in behavior, regulate emotion, and help the cognitive restructuring process. Modifying the patient's underlying dysfunctional beliefs leads to lasting improvements. In this structured therapy, the therapist and patient work collaboratively to use an approach that features reality testing and experimentation.
Method
Research Design The present study will be a feasibility rater blind randomized controlled trial study to test the efficacy of brief CBT for patients with suffering from first episode psychosis.
Sample Total 50 patients meeting the inclusion criteria of the study will be recruited from psychiatry unit of a public hospital of Raheem yar khan, Pakistan. conducted by using 50 patient met the eligibility criteria.
Instruments/Assessment Measures
The following assessment measures will be used in the research:
The Psychotic Symptom Rating Scales.
Positive and Negative Symptom Scale.
Schedule for Assessment of Insight.
Procedure
Authors of scales will be informed about usage of the scale in current research.
Get permission to Dr.Farooq Naeem usage of the CBT manual of psychosis.
SPSSv.20 for data analysis
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychosis
Keywords
cognitive behaviour therapy, first episode
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Espidone, Olepra, Donu & C.B.T
Arm Type
Experimental
Arm Description
Espidone tablet 2 mg and Donu 10 mg by mouth twice a day and Olepra tablet 5 mg by mouth at night and C.B.T 6 session program 45 minutes session after every 15 days
Arm Title
Espidone, Olepra & Donu
Arm Type
Active Comparator
Arm Description
Espidone tablet 2 mg and Donu 10 mg by mouth twice a day Olepra tablet 5 mg by mouth at night
Intervention Type
Behavioral
Intervention Name(s)
cognitive behaviour therapy
Other Intervention Name(s)
talk therapy, conversation therapy
Intervention Type
Drug
Intervention Name(s)
Espidone
Other Intervention Name(s)
risp
Intervention Type
Drug
Intervention Name(s)
Olepra
Other Intervention Name(s)
olan
Intervention Type
Drug
Intervention Name(s)
Donu
Other Intervention Name(s)
zanzia
Primary Outcome Measure Information:
Title
50 participant with schizophrenia assessed by PANSS
Description
30 item question ask from participant
Time Frame
2 hours
Title
50 participant with schizophrenia assessed by SAI
Description
three question each have two parts
Time Frame
30 mintus
Title
50 participant with schizophrenia assessed by PSRS
Description
6 item on delusion and 11 item on auditory hallucination
Time Frame
1 hour
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients diagnosed with psychosis by psychiatrist of the recruiting unit.
Patients with duration of illness till 3 years.
Patients with the minimum of 5 years of education.
Patients within the age range of 18 to 35 years.
Competent and willing to give informed consent.
Patients living in the study catchment area.
Exclusion Criteria:
Patients with drug induced psychosis.
Patients with severe psychopathology, unable to give informed consent.
Patients suffering from organic or neurological disorder.
Patients suffering from chronic physical condition.
12. IPD Sharing Statement
Citations:
PubMed Identifier
16946354
Citation
Aleman A, Agrawal N, Morgan KD, David AS. Insight in psychosis and neuropsychological function: meta-analysis. Br J Psychiatry. 2006 Sep;189:204-12. doi: 10.1192/bjp.189.3.204.
Results Reference
background
PubMed Identifier
25757714
Citation
Naeem F, Saeed S, Irfan M, Kiran T, Mehmood N, Gul M, Munshi T, Ahmad S, Kazmi A, Husain N, Farooq S, Ayub M, Kingdon D. Brief culturally adapted CBT for psychosis (CaCBTp): A randomized controlled trial from a low income country. Schizophr Res. 2015 May;164(1-3):143-8. doi: 10.1016/j.schres.2015.02.015. Epub 2015 Mar 8.
Results Reference
background
Learn more about this trial
Cbt for Psychosis and Affect on Psychosis Symptoms
We'll reach out to this number within 24 hrs